Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain

British Journal of Pharmacology

Volumn 153, Issue 4, 2008, Pages 760-768

  Rezende, R M ^a   Franca D S ^a   Menezes, G B ^a   Dos Reis, W G P ^a   Bakhle, Y S ^b   Francischi, J N ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Dipyrone; Endogenous opioids; Hypoalgesia; Paracetamol

Indexed keywords

CARRAGEENAN; DIPYRONE; NALTREXONE; PARACETAMOL; SODIUM CHLORIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; HYPERALGESIA; INFLAMMATION; MALE; MECHANICAL STIMULATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CARRAGEENAN; DIPYRONE; DISEASE MODELS, ANIMAL; HYPERALGESIA; INFLAMMATION; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RESEARCH DESIGN; TIME FACTORS;

EID: 39449100661     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707630     Document Type: Article

References (37)

1. Alloui A, Chassaing C, Schimidt J, Ardidi D, Dubray C, Cloarec A et al. (2002). Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol 443: 71-77.
2. Alves D, Duarte IDG (2002). Involvement of ATP-sensitive potassium channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol 444: 47-52.
3. 2 synthases. Clin Pharmacol Ther 79: 9-19.
4. Ayoub SS, Colville-Nash PR, Willoughby DA, Botting RM (2006). The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol 538: 57-65.
5. Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A (2003). Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology 99: 976-981.
6. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A (2005). Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114: 482-490.
7. Botting R, Ayoub SS (2005). COX-3 and the mechanism of action of acetaminophen/paracetamol. Prostaglandins Leukot Essent Fatty Acids 72: 85-87.
8. Botting RM (2000). Mechanism of action of paracetamol: is there a cyclooxygenase 3? Clin Infect Dis Suppl 5: S202-S210.
9. Brunton LL, Lazo JS, Parker KL, Buxton ILO, Blumenthal D (2005). Analgesic-antipyretic and antiinflammatory agents: pharmacotherapy of gout. In: Hardman JG, Limbrid LE (eds). Goodman & Gilman: The Pharmacological Basis of Therapeutics 11th edn. Mac Graw-Hill: New York, USA.
10. +-ATP openers and opioids. Eur J Pharmacol 417: 91-98.
11. Chandrasekharan NV, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS et al. (2002). COX-3, a cyclooxygenase-1 variant inhibited by paracetamol and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Nat Acad Sci USA 99: 13926-13931.
12. Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M et al. (2006). AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol 148: 1022-1032.
13. Di Rosa M (1972). Biological properties of the carrageenan. J Pharm Pharmacol 24: 89-102.
14. Duarte ID, Dos Santos IR, Lorenzetti B, Ferreira SH (1992). Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 217: 225-227.
15. França DS, Ferreira-Alves DL, Duarte ID, Ribeiro MC, Rezende RM, Bakhle YS et al. (2006). Endogenous opioids mediate the hypoalgesia induced by inhibitors of cyclooxygenase-2 in rat paws treated with carrageenan. Neuropharmacology 51: 37-43.
16. Francischi JN, Chaves CT, Moura ACL, Lima AS, Rocha OA, Ferreira-Alves DL et al. (2002). Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol 137: 837-844.
17. Graham GG, Scott KF (2005). Mechanism of action of paracetamol. Am J Ther 12: 46-55.
18. Hogestatt ED, Jonsson BA, Ermund A, Andersson DA, Bjork H, Alexander JP et al. (2005). Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280: 31405-31412.
19. Kis B, Snipes JA, Busija DW (2005). Paracetamol and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharm Exp Ther 315: 1-7.
20. 1 receptors. Eur J Pharmacol 531: 280-281.
21. Pereira LS, Ferreira-Alves DL, Resende MA, Romualdo MA, Dos Reis WGP, Lopes MT et al. (2003). Reduced production of hyperalgesic substances by mononuclear cells from aged rats incubated with carrageenan: role of interleukin-2 and prostaglandins. Inflamm Res 52: 119-125.
22. Pierre SC, Schmidt R, Brenneis C, Michaelis M, Geisslinger G, Scholich K (2007). Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol 151: 494-503.
23. Pini LA, Vitale G, Ottani A, Sandrini M (1997). Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 280: 934-940.
24. Raffa RB, Walker EA, Sterious SN (2004). Opioid receptors and paracetamol (acetaminophen). Eur J Pharmacol 503: 209-210.
25. Randall LO, Selitto JJ (1957). A method for measurement of analgesic activity on inflamed tissues. Arch Int Pharmacodyn Ther 111: 409-419.
26. Rang HP, Dale MM, Ritter JM, Moore P (2006). Pharmacology 6th edn. Churchill Livingstone: London.
27. + channels. Br J Pharmacol 129: 110-114.
28. + channel pathway. Proc Nat Acad Sci USA 101: 3680-3685.
29. Sandrini M, Pini LA, Vitale G (2003). Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm Res 52: 347-352.
30. Vane JR (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nat New Biol 231: 232-235.
31. Vane JR, Bakhle YS, Botting RM (1998). Cyclooxygenase-1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120.
32. Vanegas H, Tortorici V (2002). Opioidergic effects of nonopioid analgesics on the central nervous system. Cell Mol Neurobiol 22: 655-661.
33. Vasquez E, Hernandez N, Escobar W, Vanegas H (2005). Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res 1048: 211-217.
34. Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997). How opioids inhibit GABA-mediated neurotransmission. Nature 390: 611-614.
35. Vinegar R, Truax JF, Selph JL, Johnston PR, Venable AL, McKenzie KK (1987). Pathway to carrageenan-induced inflammation in the hind limb or the rat. Federation Proc 46: 118-126.
36. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 6: 109-110.
37. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, Schäfer M (2003). Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64: 202-210.